头部企业进驻、新政将出，东莞松山湖生物医药产业迎开门红

Core Viewpoint - Dongguan has reached a strategic cooperation framework agreement with CITIC Medical Health Industry Group to promote the high-quality development of the biopharmaceutical industry in Dongguan [2][3]. Group 1: Strategic Cooperation - A series of strategic cooperation agreements were signed, including a strategic cooperation agreement between Dongguan and CITIC Medical, and a fund cooperation agreement between CITIC Medical and Dongguan Investment Holding Group [3]. - CITIC Medical Group, a wholly-owned subsidiary of CITIC Group, focuses on the health industry, with main businesses including assisted reproduction, medical aesthetic services, rehabilitation, and comprehensive hospital services [3]. Group 2: Development Goals - CITIC Medical aims to implement a "two-year strong foundation, long-term rooting" strategy to empower the high-quality development of Dongguan's biopharmaceutical industry [3]. - Dongguan's development strategy targets "intelligent creation of quality products and a harmonious, livable environment," with biopharmaceuticals identified as a key emerging strategic industry [3][4]. Group 3: Industry Policy and Support - Dongguan is accelerating the creation of a biopharmaceutical and high-end medical device industry cluster, aligning CITIC Medical's services with the industrial development needs of Songshan Lake [4]. - The "Several Measures to Support the Development of Biopharmaceuticals and Future Life Health Industries in Dongguan" has completed public consultation and will be released soon, complementing local industrial policies [4].